Phase I/II Study of DFP-10917 in Patients With Acute Leukemia

NCT01702155 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphocytic Leukemia

Interventions

DRUG: DFP-10917

Sponsor

Delta-Fly Pharma, Inc.